Check Eligibility

Wegovy

Medicated Weight Management Program

How it works:

Wegovy is a GLP-1 receptor agonist that helps reducing food noise by reducing appetite, curb cravings and improve blood-sugar control.

How effective it is:

In a 68‑week trial, adults taking Wegovy alongside lifestyle changes lost on average around 15% of their body weight, significantly more than those on placebo.¹  

Start Wegovy weight management treatment with specialist review and ongoing support. 

Get Started

Who is eligible for Wegovy?

Wegovy is suitable for those who are clinically eligible and want to improve their health and their weight-related complications. Wegovy is not a shortcut or a first-line solution for weightloss, it is medicated weight management support with weightloss as one of the possible outcomes 

When Wegovy may be considered

Body‑mass criteria:

Wegovy is usually considered for adults with a BMI of over 30 or BMI of 27 with at least one weight related condition such as hypertension, PCOS and etc. 

Alongside lifestyle change

Wegovy can be used when lifestyle changes alone have not been efficient enough in managing obesity related conditions.

Structured assessment

Before starting, you complete a detailed online questionnaire covering your health, medicines and weight history so the clinician can understand your full picture. 

Clinical decision‑making

A WeightFall clinician then reviews this information and talks through your goals to decide whether Wegovy fits safely into your medicated weight management plan. 
Wegovy will be ruled out in certain situations, including if you:
  • Are pregnant, breastfeeding or hoping to become pregnant soon
  • Have previously reacted badly to semaglutide or any component of Wegovy.
  • Have a personal or family history of specific rare thyroid tumours (such as medullary thyroid carcinoma) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
  • Live with particular serious conditions affecting the gut or pancreas; these are reviewed carefully before any medicated weight management is considered. 

Find your BMI

In clinical studies, WeightFall patients lost more weight, in less time.¹

FT
  • FT
  • CM
lbs
  • lbs
  • kg
Height unit changes automatically update weight units.

Your BMI Results:

BMI Score
_
Category
_

Wegovy treatment pathway

Four simple steps so you feel informed, supported, and ready for treatment
Check Eligibility

Online medical questionnaire

You share your health and medication history. 

01

Clinician review

A clinician will check your answers and submitted photos.

02

Treatment decision 

We confirm if Wegovy is appropriate for you. 

03

Ongoing support 

Check‑ins every 3 weeks to review side effects, see how your current Wegovy dose feels, and decide whether to maintain, adjusting treatment.

04

What is Wegovy?

Wegovy is a medicine licensed for weight management in certain adults living with obesity.

It contains Semaglutide, which acts on gut hormone receptors involved in appetite and blood‑sugar control. It is used alongside diet and physical‑activity changes and is only considered where clinically appropriate.

Any decision to start or continue treatment is made by a qualified prescriber after medical review.

How does Wegovy work?

Wegovy is used as part of medicated weight management for adults who meet specific criteria.  It contains semaglutide, which acts like a natural gut hormone involved in appetite, cravings, and healthy weight management decisions. 

Reduces appetite:

Wegovy acts on areas of the brain that regulate hunger, helping you feel fuller sooner and reducing the urge to overeat.

Curbs cravings:

By mimicking GLP-1, it lowers food cravings and makes it easier to make healthier choices.

Protects the heart:

Clinical studies show semaglutide can lower the risk of cardiovascular events, such as heart attack and stroke, in people living with obesity and established cardiovascular disease.

Proven results:

In large clinical trials, people taking Wegovy lost up to 20.7% of their body weight over 72 weeks, far more than lifestyle changes alone.
Wegovy is only one part of weight management; your clinician will review wahether it remains the right option for you alongside lifestyle changes and ongoing monitoring in a medicated weight management plan. 

What Wegovy could do for you ?

Wegovy is one of the most widely studied prescription treatments for adults living with overweight or obesity. When used alongside healthy changes to eating and activity, research shows it can help many people achieve meaningful weight loss. 

In clinical studies, around 86% of people lost at least 5% of their body weight, and about half lost 15% or more ¹ when using Wegovy as part of a structured weight-management plan. Other specialist clinic data also suggests that people taking semaglutide at obesity treatment doses lost around 6% of their weight within three months, increasing to around 11% by six months. ²
 
Longer-term research indicates that weight loss with semaglutide can be maintained over time, with many people continuing to keep weight off compared with those not using treatment. Alongside weight reduction, some people also experience improvements in waist size and health markers linked to excess weight. 

Everyone responds differently. Some people notice steady changes over time, while others may see more modest results. Your clinician will review your progress regularly and will only recommend continuing treatment if it is providing meaningful benefit for you. 

weightfall-wegovy-mockup-2

It’s more than just weight loss.

What our Patients say about us

Wegovy with WeightFall has given me structure, accountability and support I’ve never had with weight programmes before. 
Sarah Thompson

Age: 36

I finally feel in control of my eating habits and long‑term health, not just chasing a target on the scales. 
James Anderson

Age: 42

Mounjaro has become part of a plan that actually fits around my routine, with my clinician checking in regularly. 
Jones Mitchell

Age: 51

Why choose

WeightFall for Wegovy? 

Focused, clinician-led weight management service to support you long term and not just a quick fix. Our clinical team consists of clinicians specialised in GLP-1 treatments and are experienced in building you a tailored weight management plan.

Health coaching

Specialist coaching supports your lifestyle changes, so Wegovy is one part of a broader and healthy weight management plan.

Access to clinicians 

UK‑registered clinicians are available to review and monitor your progress, adjust Wegovy doses and answer medical questions. 

Ongoing monitoring 

We track key health markers over time to make sure your medicated weight management treatment stays appropriate and safe. 

Convenient delivery 

Your Wegovy treatment is delivered to your chosen UK address in secure, discreet packaging.

Proven approach

Our structured pathways for Wegovy for the UK are built on clinical guidance and experience with many patients.

It’s more than just weight loss.

Wegovy Treatment Doses and Pricing

Dosage
Pricing
Review
Status
0.25mg
£139
Every 3 weeks
Starting dose
0.5mg
£149
Every 3 weeks
Titration dose
1mg
£159
Every 3 weeks
Possible maintenance dose
1.7mg
£199
Every 3 weeks
Possible maintenance dose
2.4mg
£219
Every 3 weeks
Possible maintenance dose
Feature
Wegovy (semaglutide)
Mounjaro (tirzepatide)
Dosage range
Typically increased from 0.25 mg up to 2.4 mg once weekly, following a step‑up schedule.
Typically increased from 2.5 mg up to 15 mg once weekly, following a structured titration schedule.
How often you take it
Once a week, on the same day each week.
Once a week, on the same day each week.
How long you can take it
Licensed for long‑term use for weight management under ongoing medical supervision.
Licensed for long‑term use for weight management under ongoing medical supervision.
How it works
GLP‑1 receptor agonist that curbs appetite, slows stomach emptying and supports blood‑sugar control to help reduce calorie intake.
Dual GIP and GLP‑1 receptor agonist ("twincretin") that suppresses appetite, reduces cravings and improves blood‑sugar control, with a stronger effect on metabolic pathways.
Administration
Once‑weekly self‑injectable pen used into the fatty layer under the skin (abdomen, thigh or upper arm).
Once‑weekly self‑injectable pen used into the fatty layer under the skin (abdomen, thigh or upper arm).
Price range at WeightFall
From £139 per month for Wegovy.
From £199 per month for Mounjaro.
Suitable for
Adults who meet Wegovy eligibility criteria (for example certain BMI thresholds and weight‑related health conditions) and for whom a GLP‑1‑only medicine is appropriate.
Adults who meet Mounjaro eligibility criteria and where a clinician feels a dual‑hormone medicine is suitable, particularly when additional metabolic support is needed.
Typical weight‑loss seen in trials
Many people achieved around 15–20% body‑weight reduction when Wegovy was combined with diet and activity changes.
Many people achieved around 15–23% body‑weight reduction at higher doses when Mounjaro was combined with diet and activity changes.
Wegovy has been studied in multi‑country trials lasting up to two years, with average weight reductions of around 10–17% when combined with lifestyle changes; real‑world studies report similar patterns over six months. ¹ ²